IRIS
LUZZA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.643
AS - Asia 3.979
EU - Europa 2.129
SA - Sud America 884
Continente sconosciuto - Info sul continente non disponibili 307
AF - Africa 87
OC - Oceania 21
Totale 13.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.438
SG - Singapore 1.715
CN - Cina 957
IT - Italia 898
BR - Brasile 676
VN - Vietnam 450
IN - India 386
DE - Germania 359
GB - Regno Unito 270
SE - Svezia 154
FI - Finlandia 151
CA - Canada 126
AR - Argentina 86
HK - Hong Kong 82
NL - Olanda 81
BD - Bangladesh 74
IR - Iran 56
MX - Messico 49
ID - Indonesia 37
RU - Federazione Russa 37
TR - Turchia 35
EC - Ecuador 34
JP - Giappone 31
IQ - Iraq 25
PL - Polonia 25
ES - Italia 23
ZA - Sudafrica 22
FR - Francia 21
PK - Pakistan 21
UA - Ucraina 21
CL - Cile 20
CO - Colombia 20
AU - Australia 19
IL - Israele 16
CZ - Repubblica Ceca 15
TW - Taiwan 14
MA - Marocco 13
PY - Paraguay 13
PH - Filippine 11
UZ - Uzbekistan 11
VE - Venezuela 11
PE - Perù 10
UY - Uruguay 10
AT - Austria 9
EG - Egitto 9
IE - Irlanda 9
RO - Romania 9
RS - Serbia 8
KE - Kenya 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
EU - Europa 6
DZ - Algeria 5
ET - Etiopia 5
HU - Ungheria 5
OM - Oman 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BE - Belgio 4
BH - Bahrain 4
CH - Svizzera 4
CR - Costa Rica 4
JM - Giamaica 4
JO - Giordania 4
NG - Nigeria 4
NI - Nicaragua 4
NP - Nepal 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AO - Angola 3
BO - Bolivia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
LT - Lituania 3
MG - Madagascar 3
MY - Malesia 3
PT - Portogallo 3
SC - Seychelles 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CG - Congo 2
CU - Cuba 2
GT - Guatemala 2
HN - Honduras 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
NZ - Nuova Zelanda 2
PA - Panama 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 12.738
Salva come PNG Salva come JPEG
Città #
San Jose 1.006
Singapore 555
Chandler 533
Ashburn 491
Dallas 326
Santa Clara 319
Munich 292
Bengaluru 275
Hefei 274
Milan 251
Council Bluffs 241
Chicago 235
Princeton 211
Lawrence 210
London 204
Ho Chi Minh City 176
Wilmington 132
Beijing 130
Hanoi 85
Helsinki 85
Ottawa 82
Hong Kong 72
Des Moines 68
São Paulo 67
Los Angeles 60
Catanzaro 49
Turku 48
Boardman 46
Rome 44
New York 43
Shanghai 38
Naples 34
Guangzhou 29
Redwood City 27
Mumbai 23
Cittanova 22
Hanover 22
Pune 22
Haiphong 21
Da Nang 19
Montreal 19
Norwalk 19
San Francisco 18
Rio de Janeiro 17
The Dalles 17
Bari 16
Brooklyn 16
Orem 16
Phoenix 16
Redmond 16
Warsaw 16
Istanbul 15
Palermo 15
Shenzhen 14
Tokyo 14
Belo Horizonte 13
Brasília 13
Chennai 13
Dhaka 13
Stockholm 13
Guayaquil 12
Mendicino 12
Osaka 12
Amsterdam 11
Curitiba 11
Hải Dương 11
Jyväskylä 11
Atlanta 10
Campinas 10
Charlotte 10
Cosenza 10
Mexico City 10
Salvador 10
San Nicola Manfredi 10
Tashkent 10
Thái Nguyên 10
Biên Hòa 9
Boston 9
Montevideo 9
Olomouc 9
Praia A Mare 9
Buffalo 8
Dublin 8
Jiaxing 8
Johannesburg 8
Quito 8
Santo André 8
Tehran 8
Catania 7
Collegeville 7
Fortaleza 7
Karachi 7
Manchester 7
Marília 7
Miami 7
Philadelphia 7
Santiago 7
Viamão 7
Vienna 7
Ankara 6
Totale 7.530
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 256
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 202
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials 124
Dietary polyphenolsand non-alcoholic fatty liver disease 107
Applications of Text Mining techniques to extract meaningful information from gastroenterology medical reports 101
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 96
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis 92
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study 83
Effects of Mediterranean diet supplemented with sylibin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease 83
7-Ketolithocholic acid administration in man: effects on biliary lipid composition, serum bile acid pattern and evaluation of the cholelitholytic potential 82
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 80
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 79
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 79
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 77
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 76
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 75
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 75
Antral nodularity identifies children infected with Helicobacter pylori with higher grades of gastric inflammation 74
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 74
The role of gluten-free diet in nonalcoholic fatty liver disease development 74
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 73
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 73
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopiche di mucosa gastrica antrale 73
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 73
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopicher di mucosa gastrica antrale 72
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 71
Bioactive interleukin-18 expression is up-regulated in Crohn’s disease 71
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. 71
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot study 70
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 70
Antral nodularity identifies Helicobacter pylori infected children with higher grades of gastric inflammation 70
Tumeurs benignes et malignes du duodenum 70
Altered IgG4 renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity 69
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 69
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 68
Ancient wheats: beneficial effects on insulin resistance 67
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 66
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 66
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 65
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 65
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 64
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 64
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 64
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 63
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 63
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease 63
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study 63
Alcohol consumption survey in an outpatient center of gastroenterology in southern Italy 63
Primary clarithromycin resistance in Helicobacter pylori: The multicentric Italian clarithromycin resistance observational (MICRO) study 63
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 62
Gut microbiota and non-alcoholic fatty liver disease 61
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 60
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 59
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 59
Machine Learning Approaches in Inflammatory Bowel Disease 58
Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacter Pylori infection 58
Internal medicine Magna Græcia network for the management of hepatocellular carcinoma. 57
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells 57
Bioactive IL-18 expression is up-regulated in Crohn's disease 57
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 56
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum 56
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 56
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 56
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 55
High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients 55
Ruolo della colonscopia e delle biopsie multiple nella sorveglianza dei pazienti affetti da colite ulcerosa di lunga durata 55
La calcolosi della colecisti 55
Antibacterial drugs in Crohn's disease 55
Epidemiology of Coronavirus Disease Outbreak: The Italian Trends. 55
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists 55
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells 55
Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathological features 54
Liver injury associated with high value of D-dimer plasmatic level in COVID-19 patients 53
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 53
Testing for serum IgG antibodies to Helicobacter pylori cytotoxin-associated protein detects children with higher grades of gastric inflammation 53
Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 53
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay 53
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 52
Circulating D dimer in inflammatory bowel disease 52
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 52
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients 51
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 51
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 51
Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission 51
Bone mineralization in celiac disease 51
Critical review on the use and abuse of alcohol. When the dose makes the difference. 51
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 50
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 50
Gut microbiota changes and chronic hepatitis C virus infection 50
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 50
Suggestion against an oral-oral route of transmission for Helicobacter pylori infection: a seroepidemiological study in a rural area. 50
NON ALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH INCREASED CENTRAL BODY FAT BY DUAL-ENERGY X-RAY ABSORPTIOMETRY 50
Portal hypertension-associated gastric pathology: role of endoscopic banding ligation 49
Changes in the mucosal expression of interleukin 15 in Helicobacter pylori associated gastritis 49
Treatment with phosphatidylcholine of patients with nonalcoholic fatty liver disease: a prospective pilot study 48
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report 48
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 48
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 48
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease 48
Author correction to Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells [Infect. Immun. 72, 9, (2004) 5019-5026] 48
Totale 6.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.370
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022555 0 11 16 108 54 8 20 135 54 40 89 20
2022/20231.896 426 60 72 159 186 146 31 151 291 194 147 33
2023/2024952 223 98 71 63 32 219 34 61 45 26 27 53
2024/20252.934 386 182 176 67 173 388 192 155 421 90 250 454
2025/20265.832 294 616 641 1.064 595 235 700 354 682 393 161 97
2026/2027386 100 286 0 0 0 0 0 0 0 0 0 0
Totale 13.050